S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Catalyst Pharmaceuticals Inc (CPRX)
Catalyst Pharmaceuticals Inc (CPRX) Financials

CPRX Catalyst Pharmaceuticals Inc

16.7694

0.3694 (2.25%)

18 May 2024 - Closed

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	43.09M	53.11M	57.24M	60.76M	85.37M	99.58M	102.69M	110.57M
Operating Income	17.37M	28.57M	25.1M	30.8M	35.61M	46.7M	-37.19M	41.69M
Pre Tax Income	17.46M	28.25M	26.01M	33.01M	37.31M	48.51M	-38.02M	46.71M
Net Income	13.24M	21.62M	22.75M	25.47M	29.57M	37.76M	-30.76M	34.84M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	17.46M	28.34M	25.78M	33.01M	37.31M	48.51M	-38.59M	41.69M
EBITDA	17.4M	28.61M	25.66M	31.42M	42.21M	55.27M	-28.62M	50.84M

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	500k	102.31M	119.07M	140.83M	214.2M	398.2M
Operating Income	-19.28M	-18.68M	-35.3M	31.82M	41.3M	52.39M	101.84M	86.81M
Pre Tax Income	-18.07M	-18.41M	-34M	33.41M	41.89M	52.67M	104.72M	94.51M
Net Income	-18.07M	-18.41M	-34M	31.88M	74.98M	39.48M	83.08M	71.41M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.218	-0.18	-0.331	0.308	0.723	0.383	0.789	0.67
EBIT	-19.02M	-18.23M	-34M	33.41M	41.89M	52.67M	104.72M	86.81M
EBITDA	-19.24M	-18.63M	-35.26M	32.12M	42.19M	52.58M	103.08M	119.69M

Catalyst Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions